These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 9708202)

  • 1. Levels of expression of CD19 and CD20 in chronic B cell leukaemias.
    Ginaldi L; De Martinis M; Matutes E; Farahat N; Morilla R; Catovsky D
    J Clin Pathol; 1998 May; 51(5):364-9. PubMed ID: 9708202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
    Cabezudo E; Carrara P; Morilla R; Matutes E
    Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders.
    D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Carotenuto M
    Am J Hematol; 2000 Aug; 64(4):275-81. PubMed ID: 10911380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders.
    Poongodi R; Varma N; Naseem S; Parveen B; Varma S
    Indian J Pathol Microbiol; 2018; 61(1):50-57. PubMed ID: 29567884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes.
    Wormsley SB; Baird SM; Gadol N; Rai KR; Sobol RE
    Blood; 1990 Jul; 76(1):123-30. PubMed ID: 1694698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
    Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
    Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of the monoclonal antibody, DBA44, in the diagnosis of B-lymphoid disorders.
    Salomon-Nguyen F; Valensi F; Troussard X; Flandrin G
    Leuk Res; 1996; 20(11-12):909-13. PubMed ID: 9009248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
    Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
    Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia.
    Huh YO; Keating MJ; Saffer HL; Jilani I; Lerner S; Albitar M
    Am J Clin Pathol; 2001 Sep; 116(3):437-43. PubMed ID: 11554173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD20 levels determine the in vitro susceptibility to rituximab and complement of B-cell chronic lymphocytic leukemia: further regulation by CD55 and CD59.
    Golay J; Lazzari M; Facchinetti V; Bernasconi S; Borleri G; Barbui T; Rambaldi A; Introna M
    Blood; 2001 Dec; 98(12):3383-9. PubMed ID: 11719378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of the monoclonal antibody RFB1 in chronic B-cell leukaemias.
    Melo JV; Catovsky D; Bodger M
    Scand J Haematol; 1984 Apr; 32(4):417-22. PubMed ID: 6609424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of chronic lymphoid leukaemias according to FAB.
    Oertel J; Kastner M; Bai AR; Kleiner S; Huhn D
    Leuk Res; 1992 Sep; 16(9):919-27. PubMed ID: 1405721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignancies.
    Grube M; Rezvani K; Wiestner A; Fujiwara H; Sconocchia G; Melenhorst JJ; Hensel N; Marti GE; Kwak LW; Wilson W; Barrett JA
    Clin Cancer Res; 2004 Feb; 10(3):1047-56. PubMed ID: 14871984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Density expression of the CD20 antigen on population of tumor cells in patients with chronic B-lymphocyte lymphoproliferative diseases].
    Suková V; Klabusay M; Coupek P; Brychtová Y; Doubek M; Mayer J
    Cas Lek Cesk; 2006; 145(9):712-6; discussion 716-7. PubMed ID: 17091727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
    Del Giudice I; Matutes E; Morilla R; Morilla A; Owusu-Ankomah K; Rafiq F; A'Hern R; Delgado J; Bazerbashi MB; Catovsky D
    Haematologica; 2004 Mar; 89(3):303-8. PubMed ID: 15020268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of fluorescein and phycoerythrin conjugates for quantifying CD20 expression on normal and leukemic B-cells.
    Wang L; Abbasi F; Gaigalas AK; Vogt RF; Marti GE
    Cytometry B Clin Cytom; 2006 Nov; 70(6):410-5. PubMed ID: 16967494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.
    Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
    J Clin Pathol; 1989 Jun; 42(6):567-84. PubMed ID: 2738163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.